Patrick Serruys

Showing 1-20 of 542 articles

A Comparison of Risk Prediction Models for Patients with Acute Coronary Syndromes

Hara H, O'Leary N, Ono M, Onuma Y, Serruys P

August 17, 2021 | 10.4244/EIJ-D-21-00536

Interventions for valvular disease

Chronic Hemodynamic Performance of a Biorestorative Transcatheter Heart Valve in an Ovine Model

Serruys P, Kawashima H, Chang C, Modolo R, Wang R, de Winter R, Van Hauwermeiren H, El-Kurdi M, van den Bergh W, Cox M, Onuma Y, Flameng W, Soliman O

July 20, 2021 | 10.4244/EIJ-D-21-00386

Geographical variations in left main coronary artery revascularisation: a pre-specified analysis of the EXCEL trial

Myat A, Hildick-Smith D, de Belder A, Trivedi U, Crowley A, Morice M, Kandzari D, Lembo N, Brown W, Serruys P, Kappetein A, Sabik J, Stone G

July 2, 2021 | 10.4244/EIJ-D-21-00338

Coronary interventions

Optimal Dual Antiplatelet Therapy Duration for Bioresorbable Scaffolds: an Individual Patient Data Pooled Analysis of the ABSORB Trials

Azzalini L, Ellis SG, Kereiakes D, Kimura T, Gao R, Onuma Y, Chevalier B, Dressler O, Crowley A, Zhou Z, Redfors B, Serruys P, Stone G

June 8, 2021 | 10.4244/EIJ-D-21-00263

Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy

Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein A, Head S, Onuma Y, Serruys P

May 16, 2021 | 10.4244/EIJ-D-20-00170

Statistical methods for composite endpoints

Hara H, van Klaveren D, Kogame N, Chichareon P, Modolo R, Tomaniak M, Ono M, Kawashima H, Takahashi K, Capodanno D, Onuma Y, Serruys P

April 2, 2021 | 10.4244/EIJ-D-19-00953

Impact of clinical and haemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries: a patient-level pooled analysis of the DEBATE and ILIAS studies

Stegehuis V, Wijntjens G, Bax M, Meuwissen M, Chamuleau S, Voskuil M, Koch K, Di Mario C, Vrints C, Haude M, Boersma E, Serruys P, Piek J, van de Hoef T

April 2, 2021 | 10.4244/EIJ-D-19-00774

Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

March 19, 2021 | 10.4244/EIJ-D-19-00866

Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial

Miyazaki Y, Muramatsu T, Asano T, Katagiri Y, Sotomi Y, Nakatani S, Takahashi K, Kogame N, Higuchi Y, Ishikawa M, Kyono H, Yano M, Ozaki Y, Serruys P, Okamura T, Onuma Y

March 19, 2021 | 10.4244/EIJ-D-18-00902

Coronary interventions

Age and Functional Relevance of Coronary Stenosis: a Post-Hoc Analysis of the ADVISE II Trial

Faria DC, Lee J, van der Hoef T, Mejía-Rentería H, Echavarría-Pinto M, Baptista SB, Cerrato E, García-García H, Davies J, Onuma Y, Samady H, Piek J, Serruys P, Lerman A, Escaned J

March 16, 2021 | 10.4244/EIJ-D-20-01163

Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study

Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys P

February 19, 2021 | 10.4244/EIJ-D-18-01201

Coronary interventions in 2020: the year in review

Lunardi M, Gao C, Hara H, Ono M, Kawashima H, Wang R, Wijns W, Serruys P, Onuma Y

February 5, 2021 | 10.4244/EIJ-D-20-01343

Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein A, Dressler O, Stone G

December 18, 2020 | 10.4244/EIJ-D-19-00686

Bioresorbable vascular scaffolds versus everolimus-eluting stents: a biomechanical analysis of the ABSORB III Imaging substudy

Kumar A, Gogas B, Thompson E, Burnett G, Molony D, Hosseini H, Chandran K, Lefieux A, Honda Y, Lee J, Serruys P, Kereiakes D, Stone G, Samady H

December 18, 2020 | 10.4244/EIJ-D-19-01128

A randomised controlled trial of the sirolimus-eluting biodegradable polymer ultra-thin Supraflex stent versus the everolimus-eluting biodegradable polymer SYNERGY stent for three-vessel coronary artery disease: rationale and design of the Multivessel TALENT trial

Hara H, Gao C, Kogame N, Ono M, Kawashima H, Wang R, Morel M, O'Leary N, Sharif F, Möllmann H, Reiber J, Sabaté M, Zaman A, Wijns W, Onuma Y, Serruys P

December 18, 2020 | 10.4244/EIJ-D-20-00772

BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial

Chang C, Kogame N, Asano T, von Birgelen C, Sabaté M, Onuma Y, Serruys P

December 4, 2020 | 10.4244/EIJ-D-19-00566

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

Onuma Y, Chevalier B, Ono M, Cequier A, Dudek D, Haude M, Carrié D, Sabaté M, Windecker S, Rapoza R, West N, Reith S, de Sousa Almeida M, Campo G, Iniguez-Romo A, Serruys P

December 4, 2020 | 10.4244/EIJ-D-20-00024

Immediate and long-term impact of the COVID-19 pandemic on cardiovascular clinical trials: considerations for study conduct and endpoint determination

Lansky A, Shah T, Wijns W, Stefanini G, Farb A, Kaplan A, Xu B, Pietras C, Velazquez E, Serruys P, Mahfoud F, Baumbach A

November 20, 2020 | 10.4244/EIJV16I10A147

Valvular heart interventions: advances from 2019 to 2020

Wang R, Gao C, Kawashima H, Modolo R, Rosseel L, Onuma Y, Soliman O, Serruys P, Mylotte D

November 20, 2020 | 10.4244/EIJ-D-20-00096

Clinical outcomes of TAVI or SAVR in men and women with aortic stenosis at intermediate operative risk: a post hoc analysis of the randomised SURTAVI trial

Van Mieghem N, Reardon M, Yakubov S, Heiser J, Merhi W, Windecker S, Makkar R, Cheng W, Robbins M, Fail P, Feinberg E, Stoler R, Hebeler R, Serruys P, Popma J

November 20, 2020 | 10.4244/EIJ-D-20-00303

Latest news

NEW ISSUE

Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more

September 20, 2021

STATE OF THE ART

Robotics, imaging, and artificial intelligence in the catheterisation laboratory

Rafael Beyar et al.

September 20, 2021

AHEAD OF PRINT

ViV TAVI vs repeat SAVR

Monil Majmundar et al.

September 15, 2021

AHEAD OF PRINT

Thrombectomy for ischaemic stroke

Christopher A. Rajkumar et al.

September 10, 2021

EDITORIAL

Walking the tightrope between ischaemia and bleeding

Michelle L. O’Donoghue et al.

September 20, 2021

EDITORIAL

Microvascular dysfunction endotypes and outcomes

Christos V. Bourantas et al.

September 20, 2021

EDITORIAL

Coronary sinus reducer therapy for refractory angina: is it ready for prime time?